Sysmex (OTCMKTS:SSMXY) Announces Quarterly Earnings Results

Sysmex (OTCMKTS:SSMXY) announced its quarterly earnings results on Tuesday. The company reported $0.10 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.10, Zacks reports. Sysmex had a net margin of 6.38% and a return on equity of 6.81%. The firm had revenue of $895.73 million for the quarter, compared to analyst estimates of $859.71 million. Sysmex updated its FY 2026 guidance to 0.415-0.415 EPS.

Sysmex Trading Down 3.9%

SSMXY stock opened at $12.83 on Thursday. Sysmex has a 1-year low of $8.01 and a 1-year high of $13.75. The firm has a market cap of $7.81 billion, a P/E ratio of 35.64 and a beta of 1.20. The business’s 50 day moving average is $12.04 and its 200-day moving average is $10.06. The company has a current ratio of 3.40, a quick ratio of 2.53 and a debt-to-equity ratio of 0.23.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.